TMRW Life Sciences key facts
- Operator of a fertility technology company intended to provide safety and transparency to modernize and transform egg and embryo storage.
- It has raised $198.3M across 5 recorded rounds; the latest was Early Stage VC ($38.4M) in Mar 2026.
- Notable investors include GV, Peter Thiel, What If Ventures, Casdin Capital, G9 Ventures — 17 tracked in total.
- TMRW Life Sciences has filed 6 Form Ds with the SEC since 2019, most recently Jul 2024 ($28.2M sold to 69 investors).
- Status: Privately Held (backing).
Who backs TMRW Life Sciences
17+Membership and data by Private Market View
- ·The complete investor list: 17 names
- ·Watch TMRW Life Sciences: the Monday email on marks, rounds and moves
TMRW Life Sciences funding rounds
5 roundsHow much has TMRW Life Sciences raised?
TMRW Life Sciences has raised $198 million across 5 recorded rounds since 2019. The largest was a $38.4 million early-stage round in Mar 2026.
TMRW Life Sciences has filed 6 Form Ds with the SEC since 2019, most recently in Jul 2024 ($28.2 million sold to 69 investors).
TMRW Life Sciences investors
17 investors are on record for TMRW Life Sciences, including GV, Peter Thiel, What If Ventures and Casdin Capital. By type, the record holds 4 venture capital firms, 2 private equity firms and 1 family office. The early-stage round in Mar 2026 drew 59 investors.
About TMRW Life Sciences
Operator of a fertility technology company intended to provide safety and transparency to modernize and transform egg and embryo storage. The company's technology transforms and modernizes the specimen management process using technology, automation, robotics, intuitive touchscreen software, and full-time remote monitoring that reimagines eggs and embryo handling, enabling clinics to achieve embryologist advancements in IVF technology.
- Sector
- Healthcare
- HQ
- New York, NY, United States
- Founded
- 2018
- Employees
- 82
- Website
- tmrwlifesciences.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
TMRW Life Sciences doesn't have a valuation on record yet — one is published once a priced round, a reported valuation, fund marks, or secondary prints surface in our sources. The rest of the record below builds toward it.